No doubt RJS could do an article which I know would be an interest read. Thomas Barnard piece from a while back has some good info but given Rich's knowledge, I believe he could add value. Especially, since the deal has changed to GNBT's benefit according to Joe and updating where things will be with NGIO "spinoff" wise and AE37 study. Plenty of stuff to write about. New MSO states and products(wound care).